Published in Sci Rep on January 14, 2016
The Eye As a Biomarker for Alzheimer's Disease. Front Neurosci (2016) 0.77
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol (2006) 11.23
Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci (2001) 6.32
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem (2001) 4.51
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci (2002) 4.27
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol (2009) 3.60
Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ (2004) 3.32
MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal Chem (2009) 3.30
Habituation revisited: an updated and revised description of the behavioral characteristics of habituation. Neurobiol Learn Mem (2008) 3.23
Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging (2003) 2.96
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62
Olfactory perceptual stability and discrimination. Nat Neurosci (2008) 2.52
Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 2.36
Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther (2006) 2.15
Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model. J Neurosci (2010) 2.02
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J (1998) 1.89
Enhanced urinary odor discrimination in female aromatase knockout (ArKO) mice. Horm Behav (2006) 1.83
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J (2007) 1.77
Chemical signals and parasite-mediated sexual selection. Trends Ecol Evol (1998) 1.71
Performance of mice in an automated olfactometer: odor detection, discrimination and odor memory. Chem Senses (1999) 1.64
MHC antigens in urine as olfactory recognition cues. Nature (1987) 1.64
Bidirectional plasticity of cortical pattern recognition and behavioral sensory acuity. Nat Neurosci (2011) 1.55
Sex difference in attraction thresholds for volatile odors from male and estrous female mouse urine. Horm Behav (2002) 1.46
MSClust: a tool for unsupervised mass spectra extraction of chromatography-mass spectrometry ion-wise aligned data. Metabolomics (2011) 1.37
Biomarkers of Alzheimer's disease. Neurobiol Dis (2008) 1.37
The scent of disease: volatile organic compounds of the human body related to disease and disorder. J Biochem (2011) 1.36
Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci (2008) 1.32
Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer. PLoS One (2010) 1.31
Neurobiology of a simple memory. J Neurophysiol (2008) 1.28
The scent of Mycobacterium tuberculosis--part II breath. Tuberculosis (Edinb) (2009) 1.27
Structural basis of pheromone binding to mouse major urinary protein (MUP-I). Protein Sci (2001) 1.22
Odor-guided behavior in mammals. Experientia (1986) 1.22
Review of urine microscopy for bacteriuria. JAMA (1986) 1.20
Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.16
Recognition and avoidance of the odors of parasitized conspecifics and predators: differential genomic correlates. Neurosci Biobehav Rev (2005) 1.09
Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein. J Neurochem (2003) 1.05
The smell of age: perception and discrimination of body odors of different ages. PLoS One (2012) 1.02
Genetically-based olfactory signatures persist despite dietary variation. PLoS One (2008) 0.99
Urinary volatile constituents of the house mouse,Mus musculus, and their endocrine dependency. J Chem Ecol (1986) 0.95
The scent of age. Proc Biol Sci (2003) 0.95
Pattern of volatile compounds in dominant and subordinate male mouse urine. J Chem Ecol (1989) 0.95
Volatile compound fingerprinting of mixed-culture fermentations. Appl Environ Microbiol (2011) 0.94
The role of organic volatile profiles in clinical diagnosis. Clin Chem (1981) 0.92
Mouse urinary biomarkers provide signatures of maturation, diet, stress level, and diurnal rhythm. Chem Senses (2010) 0.90
Metabolomics approach to anabolic steroid urine profiling of bovines treated with prohormones. Anal Chem (2009) 0.89
Comparative analysis of volatile constituents from mice and their urine. J Chem Ecol (2006) 0.87
Comparative evaluation of preprocessing freeware on chromatography/mass spectrometry data for signature discovery. J Chromatogr A (2014) 0.84
Genetic resistance to infection influences a male's sexual attractiveness and modulation of testosterone. Brain Behav Immun (2007) 0.84
Identification of compounds in mouse urine vapor by gas chromatography and mass spectrometry. Mech Ageing Dev (1980) 0.82
Increase in core body temperature of Alzheimer's disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis. Gerontology (2006) 0.82
Perspective: in search of biomarkers. Nature (2011) 0.81
Comparative evaluation of eight software programs for alignment of gas chromatography-mass spectrometry chromatograms in metabolomics experiments. J Chromatogr A (2014) 0.79
Animal instinct helps doctors ferret out disease. Nat Med (2011) 0.77
Urinary enzymes and their diagnostic value in human cancer. Adv Cancer Res (1965) 0.76